Insulin Lispro



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 54.5%
Gestational Diabetes 18.2%
Product Used For Unknown Indication 9.1%
Type 2 Diabetes Mellitus 9.1%
Hyperglycaemia 4.5%
Type 1 Diabetes Mellitus 4.5%
Maternal Exposure During Pregnancy 20.0%
Weight Increased 20.0%
Ketosis 15.0%
Blood Glucose Increased 10.0%
Foetal Exposure During Pregnancy 10.0%
Hyperglycaemia 5.0%
Hyperhidrosis 5.0%
Malaise 5.0%
Skin Exfoliation 5.0%
Suicide Attempt 5.0%
Secondary
Type 1 Diabetes Mellitus 25.5%
Type 2 Diabetes Mellitus 23.3%
Diabetic Ketoacidosis 15.0%
Diabetes Mellitus 10.6%
Drug Use For Unknown Indication 7.5%
Suicide Attempt 4.1%
Depression 2.2%
Acute Coronary Syndrome 1.8%
Cardiac Failure Congestive 1.3%
Angina Pectoris 1.2%
Hypertension 1.2%
Essential Hypertension 0.9%
Sleep Disorder 0.9%
Thrombosis Prophylaxis 0.9%
Hypothyroidism 0.7%
Product Used For Unknown Indication 0.7%
Blood Cholesterol Increased 0.6%
Fluid Replacement 0.6%
Gestational Diabetes 0.6%
Hyperthyroidism 0.6%
Weight Increased 13.4%
Suicide Attempt 11.0%
Death 7.3%
Wrong Drug Administered 7.3%
Drug Ineffective 6.1%
Memory Impairment 6.1%
Pregnancy 6.1%
Small For Dates Baby 6.1%
Road Traffic Accident 4.9%
Diabetic Complication 3.7%
Hypoglycaemic Coma 3.7%
Renal Failure Acute 3.7%
Vaginal Haemorrhage 3.7%
Abdominal Pain 2.4%
Asthma 2.4%
Atrial Fibrillation 2.4%
Blindness 2.4%
Blood Glucose Increased 2.4%
Cardiac Disorder 2.4%
Cerebral Haemorrhage 2.4%
Concomitant
Product Used For Unknown Indication 28.9%
Drug Use For Unknown Indication 23.6%
Diabetes Mellitus 9.1%
Hypertension 7.2%
Type 2 Diabetes Mellitus 4.4%
Rheumatoid Arthritis 3.6%
Prophylaxis 3.2%
Pain 2.4%
Graft Versus Host Disease 2.1%
Type 1 Diabetes Mellitus 2.1%
Hiv Infection 1.6%
Insomnia 1.6%
Atrial Fibrillation 1.6%
Prophylaxis Against Renal Transplant Rejection 1.6%
Nausea 1.4%
Breast Cancer 1.2%
Depression 1.1%
Neoplasm Malignant 1.1%
Premedication 1.1%
Asthma 1.1%
Vomiting 12.4%
Renal Failure Acute 8.3%
Weight Increased 7.3%
Pruritus 6.2%
Rhabdomyolysis 6.2%
Hypoglycaemia 5.2%
Nausea 5.2%
Respiratory Failure 5.2%
Peripheral Vascular Disorder 4.7%
Hyperglycaemia 4.1%
Neutropenia 4.1%
Injection Site Pain 3.6%
Somnolence 3.6%
Staphylococcal Infection 3.6%
Staphylococcal Sepsis 3.6%
Tremor 3.6%
Urinary Tract Infection 3.6%
Blood Glucose Increased 3.1%
Graft Versus Host Disease 3.1%
Myalgia 3.1%
Interacting
Type 2 Diabetes Mellitus 69.2%
Blood Cholesterol Increased 15.4%
Gastric Disorder 7.7%
Thyroid Disorder 7.7%
Gastric Disorder 50.0%
Skin Ulcer 50.0%